Journals / Respiratory Case Reports / 2016 / Cilt: 5 - Sayı: 2

Endobronşiyal Malign Melanomda Kullanılan Kriyoterapinin Nadir Bir Komplikasyonu: "Kriyoşok"

A Rare Complication of Cryotherapy Used in Endobronchial Malignant Melanoma: "Cryoshock"

Pages
77–80
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

To the best of our knowledge, there is no paper reporting cryoshock as a complication of cryotherapy application in lung malignancies in the literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Endobronchial metastases (EBMs) of malignant melanoma are rare.
📊
Key Findings & Data:A 56-year-old male patient was hospitalized for the evaluation of a lung mass.
💡
Conclusion & Impact:To the best of our knowledge, there is no paper reporting cryoshock as a complication of cryotherapy application in lung malignancies in the literature.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Endobronchial metastases (EBMs) of malignant melanoma are rare. Cryotherapy is a safe and widely used method for the treatment of EBMs. Herein, we present a malignant melanoma case with EBMs treated with cryotherapy and discuss in the light of the literature data. A 56-year-old male patient was hospitalized for the evaluation of a lung mass. Thoracic computed tomography scan showed a 3x4x7cm necrotic central mass lesion narrowing the left main bronchus. We performed rigid bronchoscopy and applied mechanical resection and cryotherapy. Biopsies revealed malignant melanoma metastases. Three days after the procedure, he was admitted to the hospital with signs of possible cryoshock. To the best of our knowledge, there is no paper reporting cryoshock as a complication of cryotherapy application in lung malignancies in the literature.

Özet

Malign melanomun endobronşiyal metastazı (EBM) nadir olarak bildirilmiştir. Kriyoterapi EBM tedavisinde yaygın olarak ve güvenle kullanılmaktadır. Kriyoterapi ile tedavi edilmiş malign melanoma bağlı bir EMB olgusunu sunmak ve ilgililiteratür ile tartışmayı amaçladık. Elli altı yaşında erkek hasta, bir akciğer kitlesinin değerlendirmesi için yatırıldı. Toraks BT'de sol ana bronşu daraltan 3x4x7cm nekrotik santral bir kitle görüldü. Rijid bronkoskopi yapıldı ve mekanik rezeksiyon ve kriyoterapi uygulandı. Biyopsiler malign melanomun metastazı olarak sonuçlandı. İşlemden üç gün sonra muhtemel kriyoşok bulgularıyla hastaneye başvurdu. Bildiğimiz kadarı ile literatürde akciğer malignitelerinde kriyoterapi kullanımının komplikasyonu olarak kriyoşoku bildiren bir yazı bulunmamaktadır.

🔖

Cite This Article

BAHADIR, A., ORTAKÖYLÜ, M. G., KİBAR, I., İLİAZ, S., ÖZGÜL, M. A., ÇETİNKAYA, E., ARDA, N. (2016). Endobronşiyal Malign Melanomda Kullanılan Kriyoterapinin Nadir Bir Komplikasyonu: "Kriyoşok". Respiratory Case Reports, Cilt: 5 - Sayı: 2, 77–80. https://ajindex.com/articles/302573

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Kiryu T, Hoshi H, Matsui E, Iwata H, Kokubo M, Shimokawa K, et al. Endotracheal/endobronchial metastases: clinicopathologic study with special reference to developmental modes. Chest 2001; 119:768-75. [CrossRef] 2. Webb WR, Gamsu G. Thoracic metastasis in malignant melanoma. A radiographic survey of 65 patients. Chest 1977; 71:176-81. 3. Bolliger CT, Mathur PN, Beamis JF, Becker HD, Cavaliere S, Colt H, et al (European Respiratory Society/American Thoracic Society). ERS/ATS statement on interventional pulmonology. European Respiratory Society/ American Thoracic Society. Eur Respir J 2002; 19:356- 73. 4. Homsi J, Kashani-Sabet M, Messina JL, Daud A. Cutaneous melanoma: prognostic factors. Cancer Control 2005; 12:223-9. 5. Akoglu S, Ucan ES, Celik G, Sener G, Sevinc C, Kılınc O, et al. Endobronchial metastases from extrathoracic malignancies. Clin Exp Metastasis 2005; 22:587-91. [CrossRef] 6. Ernst A, Feller-Kopman D, Becker HD, Mehta AC. Central airway obstruction. Am J Respir Crit Care 2004; 169:1278-97. [CrossRef] 7. Gravante G, Sconocchia G, Ong SL, Dennison AR, Lloyd DM. Immunoregulatory effects of liver ablation therapies for the treatment of primary and metastatic liver malignancies. Liver Int 2009; 29:18-24. [CrossRef] 8. Gustot T. Multiple organ failure in sepsis: prognosis and role of systemic inflammatory response. Curr Opin Crit Care 2011; 17:153-9. [CrossRef] 9. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. Chest 2009; 136(5 Suppl):e28.